Molecular and cellular mechanisms of cognitive function: implications for psychiatric disorders

[1]  D. Storm,et al.  Making New Connections Role of ERK/MAP Kinase Signaling in Neuronal Plasticity , 1999, Neuron.

[2]  K. Shen,et al.  Dynamic control of CaMKII translocation and localization in hippocampal neurons by NMDA receptor stimulation. , 1999, Science.

[3]  M. Nordlund,et al.  Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor , 1999, Brain Research.

[4]  M. Zöller,et al.  A psychiatric 12-year follow-up of adult patients with neurofibromatosis type 1. , 1999, Journal of psychiatric research.

[5]  L. Klesse,et al.  p21 Ras and Phosphatidylinositol-3 Kinase Are Required for Survival of Wild-Type and NF1 Mutant Sensory Neurons , 1998, The Journal of Neuroscience.

[6]  G. MacQueen,et al.  Increased temporal cortex CREB concentrations and antidepressant treatment in major depression , 1998, The Lancet.

[7]  A. Riccio,et al.  Identification and Characterization of Novel Substrates of Trk Receptors in Developing Neurons , 1998, Neuron.

[8]  R. Morris,et al.  Impaired spatial learning after saturation of long-term potentiation. , 1998, Science.

[9]  A. Beaudet,et al.  Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. , 1998, Learning & memory.

[10]  J. Gault,et al.  Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). , 1998, Genomics.

[11]  E R Kandel,et al.  Different training procedures recruit either one or two critical periods for contextual memory consolidation, each of which requires protein synthesis and PKA. , 1998, Learning & memory.

[12]  J. Roder,et al.  Multiple behavioral anomalies in GluR2 mutant mice exhibiting enhanced LTP , 1998, Behavioural Brain Research.

[13]  T. Manabe,et al.  Increased Thresholds for Long-Term Potentiation and Contextual Learning in Mice Lacking the NMDA-type Glutamate Receptor ε1 Subunit , 1998, The Journal of Neuroscience.

[14]  Michael J. Rowan,et al.  Spatial exploration induces a persistent reversal of long-term potentiation in rat hippocampus , 1998, Nature.

[15]  T. Manabe,et al.  Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors , 1998, Nature.

[16]  A. Wittinghofer,et al.  Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1. , 1998, Human molecular genetics.

[17]  E. Kandel,et al.  Inducible and Reversible Gene Expression with the rtTA System for the Study of Memory , 1998, Neuron.

[18]  C Kentros,et al.  Abolition of long-term stability of new hippocampal place cell maps by NMDA receptor blockade. , 1998, Science.

[19]  S. Shenolikar,et al.  Gating of CaMKII by cAMP-regulated protein phosphatase activity during LTP. , 1998, Science.

[20]  Alcino J. Silva,et al.  Autophosphorylation at Thr286 of the alpha calcium-calmodulin kinase II in LTP and learning. , 1998, Science.

[21]  Howard Eichenbaum,et al.  Abnormal hippocampal spatial representation in aCaMKIIT286A and CREBaD-mice , 1998 .

[22]  P. De Koninck,et al.  Sensitivity of CaM kinase II to the frequency of Ca2+ oscillations. , 1998, Science.

[23]  E. Kandel,et al.  Genetic and Pharmacological Evidence for a Novel, Intermediate Phase of Long-Term Potentiation Suppressed by Calcineurin , 1998, Cell.

[24]  Eric R Kandel,et al.  Restricted and Regulated Overexpression Reveals Calcineurin as a Key Component in the Transition from Short-Term to Long-Term Memory , 1998, Cell.

[25]  M. McKERNAN,et al.  Fear conditioning induces a lasting potentiation of synaptic currents in vitro , 1997, Nature.

[26]  Joseph E LeDoux,et al.  Fear conditioning induces associative long-term potentiation in the amygdala , 1997, Nature.

[27]  D. Glanzman,et al.  Mediation of classical conditioning in Aplysia californica by long-term potentiation of sensorimotor synapses. , 1997, Science.

[28]  Jonathan C. Gewirtz,et al.  Second-order fear conditioning prevented by blocking NMDA receptors in amygdala , 1997, Nature.

[29]  E. Nestler,et al.  A molecular and cellular theory of depression. , 1997, Archives of general psychiatry.

[30]  T. Soderling,et al.  Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation. , 1997, Science.

[31]  D. Gutmann,et al.  Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules , 1997, Brain Research.

[32]  Y. Zhong,et al.  Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides. , 1997, Science.

[33]  J. Gusella,et al.  Rescue of a Drosophila NF1 mutant phenotype by protein kinase A. , 1997, Science.

[34]  L. Bäckman,et al.  Neuropsychological deficits in adults with Neurofibromatosis type 1 , 1997, Acta neurologica Scandinavica.

[35]  E. Kandel,et al.  Genetic Demonstration of a Role for PKA in the Late Phase of LTP and in Hippocampus-Based Long-Term Memory , 1997, Cell.

[36]  K. I. Blum,et al.  Impaired Hippocampal Representation of Space in CA1-Specific NMDAR1 Knockout Mice , 1996, Cell.

[37]  David J. Anderson,et al.  Subregion- and Cell Type–Restricted Gene Knockout in Mouse Brain , 1996, Cell.

[38]  M. Fanselow,et al.  N-methyl-D-aspartate receptors in the basolateral amygdala are required for both acquisition and expression of conditional fear in rats , 1996 .

[39]  E. Kandel,et al.  Toward a molecular definition of long-term memory storage. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[40]  D. Gutmann,et al.  Expression of a developmentally-regulated neuron-specific isoform of the neurofibromatosis 1 (NF1) gene , 1996, Neuroscience Letters.

[41]  B. Korf,et al.  Neurobehavioral profiles of children with neurofibromatosis 1 referred for learning disabilities are sex-specific. , 1996, American journal of medical genetics.

[42]  R. Duman,et al.  Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[43]  Linda J. Schuerholz,et al.  Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1. , 1996, American journal of medical genetics.

[44]  S. Hyman,et al.  Initiation and adaptation: a paradigm for understanding psychotropic drug action. , 1996, The American journal of psychiatry.

[45]  E R Kandel,et al.  Presynaptic facilitation revisited: state and time dependence , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[46]  J. Steyaert,et al.  Neurofibromatosis type 1 in childhood: correlation of MRI findings with intelligence. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[47]  C. Altar,et al.  Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[48]  R. Iyengar,et al.  Postsynaptic CAMP pathway gates early LTP in hippocampal CA1 region , 1995, Neuron.

[49]  D. Cain,et al.  Spatial learning without NMDA receptor-dependent long-term potentiation , 1995, Nature.

[50]  R. Morris,et al.  Distinct components of spatial learning revealed by prior training and NMDA receptor blockade , 1995, Nature.

[51]  R. Duman,et al.  Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[52]  N. Copeland,et al.  Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons , 1995, Cell.

[53]  Joseph E. LeDoux,et al.  LTP is accompanied by commensurate enhancement of auditory-evoked responses in a fear conditioning circuit , 1995, Neuron.

[54]  M. Nordlund,et al.  Neurofibromin Expression and Astrogliosis in Neurofibromatosis (Type 1) Brains , 1995, Journal of neuropathology and experimental neurology.

[55]  K. North,et al.  COGNITIVE FUNCTION AND ACADEMIC PERFORMANCE IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 , 1995, Developmental medicine and child neurology.

[56]  G. Vassal,et al.  Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5' part of the gene. , 1995, Human molecular genetics.

[57]  D. Gutmann,et al.  Expression of the neurofibromatosis 1 (NF1) isoforms in developing and adult rat tissues. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[58]  Alcino J. Silva,et al.  Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein , 1994, Cell.

[59]  B L McNaughton,et al.  LTP saturation and spatial learning disruption: effects of task variables and saturation levels , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[60]  Robert A. Weinberg,et al.  Tumour predisposition in mice heterozygous for a targeted mutation in Nf1 , 1994, Nature Genetics.

[61]  F. Collins,et al.  DNA sequences in the promoter region of the NF1 gene are highly conserved between human and mouse. , 1994, Genomics.

[62]  N. Copeland,et al.  Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. , 1994, Genes & development.

[63]  K. North,et al.  Specific learning disability in children with neurofibromatosis type 1 , 1994, Neurology.

[64]  R. Papke,et al.  A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus , 1994, Neuroscience Letters.

[65]  D. Lowy,et al.  Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function , 1994, Molecular and cellular biology.

[66]  Michael Davis,et al.  Fear-potentiated startle: A neural and pharmacological analysis , 1993, Behavioural Brain Research.

[67]  V. Doyère,et al.  Long-term potentiation of hippocampal afferents and efferents to prefrontal cortex: Implications for associative learning , 1993, Neuropsychologia.

[68]  K. North.  Neurofibromatosis Type 1: Review of the First 200 Patients in an Australian Clinic , 1993, Journal of child neurology.

[69]  D. Easton,et al.  An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. , 1993, American journal of human genetics.

[70]  J. Gusella,et al.  Mouse neurofibromatosis type 1 cDNA sequence reveals high degree of conservation of both coding and non-coding mRNA segments. , 1993, Human molecular genetics.

[71]  Joseph E. LeDoux,et al.  Somatosensory and auditory convergence in the lateral nucleus of the amygdala. , 1993, Behavioral neuroscience.

[72]  R. Hughes,et al.  MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[73]  M. Nordlund,et al.  Neurofibromin is enriched in the endoplasmic reticulum of CNS neurons , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[74]  T. Bliss,et al.  A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.

[75]  J. Connor,et al.  Specific involvement of Ca(2+)-calmodulin kinase II in cholinergic modulation of neuronal responsiveness. , 1992, Journal of neurophysiology.

[76]  H. Schulman,et al.  Calmodulin Trapping by Calcium-Calmodulin-Dependent Protein Kinase , 1992, Science.

[77]  M. Daston,et al.  The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes , 1992, Neuron.

[78]  F. Tamanoi,et al.  The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae , 1990, Cell.

[79]  P. O’Connell,et al.  The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21 , 1990, Cell.

[80]  M. Wigler,et al.  The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins , 1990, Cell.

[81]  Michael Davis,et al.  Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala , 1990, Nature.

[82]  J. Charrow,et al.  Neurofibromatosis type 1 in childhood. , 1990, The Journal of pediatrics.

[83]  H. Matthies,et al.  In search of cellular mechanisms of memory , 1989, Progress in Neurobiology.

[84]  J. Dambrosia,et al.  Neurofibromatosis type 1 (Recklinghausen's disease). Neurologic and cognitive assessment with sibling controls. , 1989, American journal of diseases of children.

[85]  D. Shucard,et al.  The significance of MRI abnormalities in children with neurofibromatosis , 1989, Neurology.

[86]  C. Varnhagen,et al.  Neurofibromatosis and Psychological Processes , 1988, Journal of developmental and behavioral pediatrics : JDBP.

[87]  J. Lisman,et al.  Feasibility of long-term storage of graded information by the Ca2+/calmodulin-dependent protein kinase molecules of the postsynaptic density. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[88]  M. Eliason.  Neurofibromatosis: implications for learning and behavior. , 1986, Journal of developmental and behavioral pediatrics : JDBP.

[89]  R Freedman,et al.  Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. , 1982, Biological psychiatry.

[90]  B L McNaughton,et al.  Long‐term synaptic enhancement and short‐term potentiation in rat fascia dentata act through different mechanisms , 1982, The Journal of physiology.

[91]  J. O'Keefe,et al.  The hippocampus as a spatial map. Preliminary evidence from unit activity in the freely-moving rat. , 1971, Brain research.

[92]  小埜 良一.  Recklinghausen氏病(Neurofibromatosis)の骨変化について , 1958 .

[93]  D. Rosielle,et al.  Psychiatry , 1905, NeuroImage.

[94]  P. Frankland,et al.  A mouse model for the learning and memory deficits associated with neurofibromatosis type I , 2002, Nature Genetics.

[95]  R Freedman,et al.  Schizophrenia, sensory gating, and nicotinic receptors. , 1998, Schizophrenia bulletin.

[96]  H Eichenbaum,et al.  Abnormal hippocampal spatial representations in alphaCaMKIIT286A and CREBalphaDelta- mice. , 1998, Science.

[97]  Alcino J. Silva,et al.  CREB and memory. , 1998, Annual review of neuroscience.

[98]  M. Fanselow,et al.  N-methyl-D-aspartate receptors in the basolateral amygdala are required for both acquisition and expression of conditional fear in rats. , 1996, Behavioral neuroscience.

[99]  K. Tchangaï-Walla,et al.  [Von Recklinghausen neurofibromatosis in Lome, Togo]. , 1995, Medecine tropicale : revue du Corps de sante colonial.

[100]  Joseph E LeDoux.  Emotion: clues from the brain. , 1995, Annual review of psychology.

[101]  A. Paller.  Neurofibromatosis type 1: The cognitive phenotype , 1995 .

[102]  R. Hughes,et al.  The Neurofibromatoses : a pathogenetic and clinical overview , 1994 .

[103]  Chris R. Brewin,et al.  COGNITIVE-PSYCHOLOGY AND EMOTIONAL DISORDERS - WILLIAMS,JMG, WATTS,FN, MACLEOD,C, MATHEWS,A , 1989 .

[104]  M. Eliason.  Neuropsychological patterns: neurofibromatosis compared to developmental learning disorders. , 1988, Neurofibromatosis.

[105]  Eliason Mj.  Neuropsychological patterns: neurofibromatosis compared to developmental learning disorders. , 1988 .

[106]  G. Lynch,et al.  Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5 , 1986, Nature.